What it’s about
The Cognition Stack combines three established neurotropic compounds from the Russian and Eastern European research tradition. In preclinical models, these peptides are frequently investigated in parallel because they address complementary neuronal pathways: BDNF modulation, GABAergic anxiolysis and cellular plasticity.
The community typically combines these compounds in setups designed to cover multiple cognitive and stress resilience axes simultaneously. Each individual compound has substantial data; the combination reflects an established configuration in neuro research.
The Compounds
Semax is a synthetic heptapeptide fragment of the ACTH molecule. In research models, the compound is associated with BDNF elevation, neurotrophic properties and effects on cognitive endpoints. Substantial research history from Russian neuro research.
Selank is a synthetic heptapeptide analog of the tuftsin molecule. In preclinical studies, the compound is linked to anxiolytic effects without sedative components. GABAergic modulation runs through an indirect pathway without classical benzodiazepine binding.
Pinealon is a synthetic tripeptide from the Khavinson bioregulator school. In research models, the compound is associated with cellular plasticity in neuronal tissues and neuroprotective properties.
Research Context
In preclinical studies, semax and selank are frequently investigated in parallel because they cover complementary axes (BDNF axis vs. anxiolytic axis). Pinealon extends coverage to the cellular plasticity axis from the Khavinson tradition. The stack is thus a three-layered neurotropic research tool for comprehensive cognitive study designs.
This information is for research and educational purposes only. No medical recommendations.